<DOC>
	<DOCNO>NCT00735475</DOCNO>
	<brief_summary>The purpose study determine immunogenicity safety profile CSL Limited 's Influenza Virus Vaccine compare US Licensed Comparator Influenza Virus Vaccine .</brief_summary>
	<brief_title>A Study Determine Immunogenicity Safety Profile CSL Limited 's Influenza Virus Vaccine Compared US Licensed Comparator Influenza Virus Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Males age ≥ 65 year females nonchildbearing potential age ≥ 65 year ; 2 . Written informed consent ; 3 . Willingness provide blood sample . 1 . Known hypersensitivity previous dose influenza vaccine allergy egg , chicken protein , neomycin , polymyxin , component Study Vaccines ; 2 . Previous vaccination influenza 2008 2009 seasonal trivalent inactivate influenza vaccine ; 3 . Known history GuillainBarré Syndrome ; 4 . Clinical sign active infection and/or oral temperature great equal 100 degree F ( 37.8 degree C ) . 5 . Have active recent clinically significant gastrointestinal/hepatic , renal , neurological , cardiovascular , respiratory , endocrine disorder medical disorder ; 6 . History seizure ; 7 . Confirmed suspected immunosuppressive condition , previously diagnose immunodeficiency disorder ; 8 . Clinically significant history malignancy 9 . Current treatment , treatment radiotherapy cytotoxic drug time six month prior administration Study Vaccine ; 10 . Current immunosuppressive immunomodulative therapy ; 11 . Administration immunoglobulins and/or blood product within 3 month precede administration Study Vaccine ; 12 . Participation clinical trial use investigational compound within 30 day prior receive Study Vaccine ; 13 . Vaccination register vaccine within 14 day ( inactivated vaccine ) 28 day ( live vaccine ) prior receive Study Vaccine . 14 . Current treatment warfarin anticoagulant ; 15 . Major congenital defect ; 16 . Evidence , history ( within previous 12 month ) drug alcohol abuse ; 17 . Unwillingness inability comply study protocol include completion adverse event diary card ; 18 . History psychiatric disorder ; 19 . Resident long term care facility .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>